Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0001209191-20-028490

Options or other derivatives

  • Director acquired 1,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Morich Frank Director 2020-05-11 Grant or award · Stock Option (right to buy) +1,200 1,200 D
Loading xslF345X03/doc4.xml…